EDGAR Filing Documents for 0001493152-22-004471

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001493152-22-004471

Filing Date

2022-02-14

Accepted

2022-02-14 16:32:21

Documents

Period of Report

2021-12-31

Document Format Files

Seq	Description	Document	Type	Size
1		form10-q.htm iXBRL	10-Q	1555974
2		ex31-1.htm	EX-31.1	20022
3		ex31-2.htm	EX-31.2	13212
4		ex32-1.htm	EX-32.1	4253
5		ex32-2.htm	EX-32.2	4204
	Complete submission text file	0001493152-22-004471.txt		7487164

Data Files

Seq	Description	Document	Type	Size
6	XBRL SCHEMA FILE	eltp-20211231.xsd	EX-101.SCH	54281
7	XBRL CALCULATION FILE	eltp-20211231_cal.xml	EX-101.CAL	65795
8	XBRL DEFINITION FILE	eltp-20211231_def.xml	EX-101.DEF	180247
9	XBRL LABEL FILE	eltp-20211231_lab.xml	EX-101.LAB	418364
10	XBRL PRESENTATION FILE	eltp-20211231_pre.xml	EX-101.PRE	322385
79	EXTRACTED XBRL INSTANCE DOCUMENT	form10-q_htm.xml	XML	1451977

Mailing Address 165 LUDLOW AVENUE NORTHVALE NJ 07647

Business Address 165 LUDLOW AVENUE NORTHVALE NJ 07647 2017502646

ELITE PHARMACEUTICALS INC /NV/ (Filer) CIK: 0001053369 (see all company filings)